Filter
332
Filtered Results: 332
Text search:
incidences
d'ebola
Featured
Recommendations
40
New Publications
100
Language
Document type
No document type
159
Studies & Reports
78
Guidelines
42
Manuals
23
Strategic & Response Plan
14
Fact sheets
8
Training Material
4
Situation Updates
4
Countries / Regions
Sierra Leone
36
Liberia
31
Global
26
Congo, Democratic Republic of
14
Guinea
11
Africa
8
West and Central Africa
8
East and Southern Africa
7
Nigeria
6
Ghana
5
Benin
5
Senegal
5
Burkina Faso
5
Mali
5
Kenya
4
Latin America and the Carribbean
4
Western and Central Europe
4
Rwanda
3
Cameroon
3
Germany
3
Eastern Europe
3
Zambia
3
India
3
Nepal
2
Mozambique
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Uganda
2
Russia
2
Central African Republic
2
Ethiopia
2
Angola
2
South Sudan
2
Pakistan
2
Ukraine
1
Togo
1
China
1
Afghanistan
1
Burundi
1
Malawi
1
Philippines
1
Asia
1
Guinea-Bissau
1
Tanzania
1
Middle East and North Africa
1
South–East Asia Region
1
Bangladesh
1
South Africa
1
Vietnam
1
Brazil
1
Sri Lanka
1
Chad
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
108
Key Resources
28
Public Health
17
Clinical Guidelines
16
Women & Child Health
10
Capacity Building
5
Pharmacy & Technologies
5
Toolboxes
Ebola & Marburg
60
COVID-19
57
Rapid Response
25
Planetary Health
23
AMR
15
HIV
13
Caregiver
12
Global Health Education
11
Health Financing Toolbox
10
TB
8
Mental Health
6
Natural Hazards
5
NTDs
5
Conflict
4
Zika
4
Refugee
3
Disability
3
Pharmacy
3
Polio
2
Specific Hazards
1
Social Ethics
1
Malaria
1
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Orientations provisoires
A wide range of potential enablers and barriers were identified for influencing progress for the scale-up of severe wasting services within national health systems. Findings were categorised according to the six pillars of WHO’s health system strengthening framework.
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
- Module 1: Understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition
Coronavirus disease 2019 (COVID-19) has a wide range of documented effects. It directly causes death and disability for some people infected. However, disruption to...
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
This report explores the extent to which evidence, policy, normative guidance and commitments on HIV and gender-based violence, and their interlinkages, is being translated into action on the ground in fragile settings. These issues are explored through the lens of training of peace support operatio...
Interim practical manual supporting implementation of the WHO guidelines on core components of infection prevention and control programmes
Regional Operational Plan 2016 FY17 Strategic Direction Summary
2 May 2016
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Epidemiologisches Bulletin; 1. Dezember 2014 / Nr. 48
